Trinity Biotech has announced a $45 million (€41.5m) investment from the South Korean MiCo Group, which will now own 29.9pc of the listed company. “I am excited that we are entering into this strategic partnership with MiCo,” said Mr O’Caoimh. “I believe that this investment together with access to MiCo’s technological expertise and geographic networks positions Trinity Biotech for exciting growth and will accelerate the further development and commercialisation of Trinity Biotech’s diagnostic platforms. The founder and chair of MiCo, Mr Sun-Q Jeon, will become chairperson of Trinity Biotech. CEO Ronan O’Caoimh and CFO John Gillard will both remain board members.

Source: Irish Independent April 13, 2022 12:05 UTC